Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Research And Development Expense of $20.28 million for the year ending 2025.
- TREACE MEDICAL CONCEPTS, INC. showed a decrease of -1.5% in Research And Development Expense from 2024 to 2025.
- This data is from TREACE MEDICAL CONCEPTS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), TREACE MEDICAL CONCEPTS, INC.'s Research And Development Expense has grown by 300.0%.
- Historical annual values: Fiscal year 2025: $20.28 million | Fiscal year 2024: $20.59 million | Fiscal year 2023: $15.44 million | Fiscal year 2022: $13.58 million | Fiscal year 2021: $10.20 million | Fiscal year 2020: $5.85 million | Fiscal year 2019: $5.07 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: